Objective: Human leukocyte antigen (HLA)-B*40:36 is a low incidence allele in the HLA-B locus. This study reports the ethnicity of B*40:36 and the deduced probable HLA haplotype associated with HLA-B*40:36 in Taiwanese unrelated bone marrow hematopoietic stem cell donors. Materials and methods: A sequence-based typing method was employed to confirm that the low incidence allele was present. Polymerase chain reaction was performed to amplify exons 2 and 3 in the HLA-A and HLA-B loci and exon 2 in the HLA-DRB1 locus using group-specific primer sets. The amplicons were sequenced using the BigDye Terminator Cycle Sequencing Ready Reaction Kit in both directions. Results: The DNA sequence of B*40:36 is identical to B*40:01:01 in exons 2 and 3, except for a one nucleotide substitution at residue 419 (A/T), which results in a one amino acid replacement at position 116 (Y/F; tyrosine/phenylalanine). We deduced the probable HLA haplotype in an association with B*40:36 in Taiwanese to be A*02-B*40:36-DRB1*12. Conclusion: Information on the deduced probable HLA haplotype in an association with the low incidence B*40:36 allele that we report here is of value for HLA testing laboratories for reference purposes. In addition, it can be used by stem cell transplantation donor search coordinators to determine the likelihood of finding compatible donors in unrelated bone marrow donor registries when a patient has this uncommon HLA allele.
Introduction
New human leukocyte antigen (HLA) alleles continue to be discovered and the recognition of HLA low incidence alleles has enriched our understanding of the complexity of the HLA system. The major histocompatibility complex (MHC) in humans consists of several loci of genes that are located on the short arm of chromosome 6 at 6p21.3. These loci are classified into MHC class I, II, and III regions. The genes encoding the HLA alleles are located in the MHC class I and II regions. The HLA genes are characterized by their extreme allelic polymorphism as well as their variations and diversity among different ethnic groups and racial populations. HLA molecules have been definitely defined as transplant antigens and have a strong relevance to tissue transplantation. Their molecule similarity between donors and recipients is being considered to be a predictive factor for graft survival and graft versus host disease. It is imperative to characterize precisely any unknown and low incidence alleles encountered during routine HLA typing procedures. To facilitate successful and comprehensive unrelated bone marrow hematopoietic stem cell donor searches for patients in need of hematopoietic stem cell transplantation, a persistent effort is needed to resolve unidentified, ambiguous or low incidence alleles in order to offer a better service in terms of HLA matching and donor selection. 
Materials and methods
Peripheral whole blood samples from unrelated bone marrow hematopoietic stem cell donors with Taiwanese ethnicity were collected in acid citrate dextrose anticoagulant. Formal written consent was signed by the donors prior to blood collection. The whole blood samples were stored at À80 C until use. Genomic DNA was extracted using the QIAamp DNA Blood Mini Kit according to the manufacturer's instructions (Qiagen, Hilden, Germany). The DNA material was subjected to HLA genotyping for the HLA-A, HLA-B, and HLA-DRB1 loci using a commercial polymerase chain reactionsequencing based typing kit, namely the SeCore A/B/DRB1 Locus Sequencing kit (Life Technologies, Brown Deer, WI, USA). Highresolution allelic sequencing was performed as previously described [2e6]. The two sets of primer sequences used were: 1. B-CG: M13-BIN1-CGG (sense): TgTAAAACgACggCCAgTCgggggCgCAggACCCgg; P3 0 exon 5B (antisense): gCTCCgATgACCACAACTgCT and 2. B-TA: M13-BIN1-TGA (sense): TgTAAAACgACggCCAgTggCgggggCgCAggACCTgA; and P3 0 exon 5B (antisense): gCTCCgATgACCACAACTgCT. The amplicons were sequenced using a BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA) in both directions.
Results
We confirmed that the DNA sequence of B*40:36 was identical to B*40:01:01 in exons 2 and 3, except for a one nucleotide substitution at residue 419 (A/T; Fig. 1 ) which results in one amino acid replacement at position 116 (tyrosine/phenylalanine; Y/F; Fig. 2 ). The extended HLA-A, HLA-B, and HLA-DRB1 typing of our eight bone marrow stem cell donors with B*40:36 are shown in Table 1 . Based on the commonly shared HLA alleles of the eight donors with B*40:36 in Table 1 , we deduced the probable HLA haplotype in an association with B*40:36 for our Taiwanese unrelated bone marrow donors to be A*02-B*40:36-DRB1*12. Our observation also indicated the Taiwanese ethnicity of the rare HLA-B allele, B*40:36.
Discussion
We confirmed the DNA sequence and amino acid sequence of the low frequency HLA allele B*40:36 in this study. B*40:36 was initially discovered in an individual (IMGT access number HLA01482) with HLA typing of A*24, A*34, B*15:21, B*40:36 [1] , but this was without information on the individual's ethnicity and the associated HLA haplotype. Two probable B*40:36 associated HLA-A-B haplotypes may be deduced from this donor and these are A*24-B*40:36 and A*34-B*40:36. In this study we have been able to deduce the probable HLA A-B-DRB1 haplotype from the eight Taiwanese unrelated bone marrow stem cell donors with A*40:36, based on their commonly shared HLA-A, HLA-B, and HLA-DRB1 alleles, to be A*02-B*40:36-DRB1*12 ( Table 1 The significance of determining the ethnicity of B*40:36 and its linked HLA haplotype is that the information may now be employed in anthropological investigation of races. In addition, it allows search coordinators using unrelated bone marrow donor registries to allocate appropriate unrelated bone marrow hematopoietic stem cell donors if their patient is carrying B*40:36. Additionally, to know the nucleotide and amino acid variation between B*40:36 and the prevalently observed B*40:01:01 allele may be helpful in hematopoietic stem cell transplantation when selecting a minor HLA mismatched unrelated bone marrow stem cell donor for a patient bearing the rare B*40:36 allele.
It is worth mentioning that the most direct and classic method of determining HLA haplotypes is through a family study if test materials from a number of key family members are available. Alternatively, a population study may be employed if there is a significant and sufficient number of unrelated donors available [7] . However, the haplotypes deduced via population investigation are considered to be likely or most probable. In this study, due to the lack of availability of the necessary test material from the families, we opted to determine the haplotypes by looking at the HLA alleles carried in common by the unrelated donors bearing the same alleles of interest. By the same token, if determination of plausible HLA associated haplotypes is for a rare or low frequency HLA allele, the alleles shared in common by unrelated individuals may be employed to deduce the associated probable haplotypes [8e15]. The frequency of B*40:36 in Taiwanese is extremely low at about 1 in 20,000 according our HLA typing practice and the Allele Frequencies in World Population (http://www.allelefrequencies.net/ hla6006a.asp?hla_locus_type¼Classical#). Therefore, we think the probable B*40:36 associated HLA haplotypes in Taiwanese that we deduced in this study is accurate. The number of HLA alleles is ever exponentially increasing with the recent development of DNA-based molecular typing technology. By contrast, an outstanding level of the HLA diversity is found in every ethnic group and this diversity is unique and important. Facilitating an appropriate HLA-matched unrelated bone marrow stem cell donor for a given needy patient that allows successful bone marrow stem cell transplantations relies on the accuracy of HLA typing result. This is dependent on the spirit and strength needed to resolve unknown, ambiguous, and low incidence genes in the HLA system. Our challenge is enormous and most rewarding.
